Message from the President
Prof. A. V. Ramachandran
The time of our 39th annual meeting is rapidly approaching, just three months away. It will always be fun to see Society members together again for our annual 'fusion' event.
Post-covid 2022, after the first quarter, has begun positively with soaring spirits with the announcement of the 39th annual meet of the Society by the CCMB-HCU group headed by Dr Umapathi and Dr Suresh Yenugu. Along with the SRBCE members, I would like to thank Dr Suttur Malini and her team at the Department of Genetics and Genomics University of Mysore for organizing the 38th annual meet on a hybrid platform with the able assistance and guidance from Dr.T.Shivanandappa, a live wire of our Society. The meeting was indeed refreshing after the washout of the previous two meetings due to the ravaging Covid pandemic.
I will be failing in my duties if I don't mention the commendable progress that our Society Journal (JRE) has made regarding the quality of articles, the get-up, coverage, and recognition. For this, I would like to thank our heroes, Prof. Akbarsha, for his tireless dedication with a singular motive and his editorial board team.
To touch upon the ethos of the Society, I would like to mention one aspect dear to my heart that is posing a global health threat. Like hormones, EDCs are active at very low concentrations and can cause adverse health effects, most of which are not evaluated in traditional toxicology assays. It is of utmost necessity that regulatory decisions on EDCs are made based on scientific expertise involving reproductive biology, endocrinology, medicine, genetics, behaviour, developmental biology and last but not the least, toxicology. Perceptibly, the incidence of chronic diseases is now greater than infectious diseases, and remarkably, most of them have an endocrine basis.
